Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.035 SGD
43.79 M SGD
78.18 M SGD
193.60 M
About TALKMED
Sector
Industry
CEO
Peng Tiam Ang
Website
Headquarters
Singapore
Founded
2013
ISIN
SG2G61000003
FIGI
BBG005SX77F6
TalkMed Group Ltd. is an investment holding company, which engages in the provision of tertiary healthcare services. It operates through the Oncology Services and Cellular and Gene Therapy Related Products and Services segments. The Oncology Services segment offers assistance to Parkway Cancer Centre. The company was founded on September 10, 2013 and is headquartered in Singapore.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 5G3 is 0.440 SGD — it has increased by 2.30% in the past 24 hours. Watch TALKMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SGX exchange TALKMED stocks are traded under the ticker 5G3.
5G3 stock hasn't changed in a week, the last month showed zero change in price, over the last year TALKMED has showed a 4.76% increase.
5G3 stock is 2.30% volatile and has beta coefficient of 0.25. Track TALKMED stock price on the chart and check out the list of the most volatile stocks — is TALKMED there?
Yes, you can track TALKMED financials in yearly and quarterly reports right on TradingView.
TALKMED is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
5G3 net income for the last half-year is 33.99 M SGD, while the previous report showed 9.80 M SGD of net income which accounts for 246.64% change. Track more TALKMED financial stats to get the full picture.
As of Apr 17, 2025, the company has 270 employees. See our rating of the largest employees — is TALKMED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TALKMED EBITDA is 35.26 M SGD, and current EBITDA margin is 45.10%. See more stats in TALKMED financial statements.
Like other stocks, 5G3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TALKMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TALKMED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TALKMED stock shows the buy signal. See more of TALKMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.